Ratings by Cantor Fitzgerald (Joshua Schimmer)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/14/2026 4D Molecular Therapeutics FDMT Upgrade Overweight
(Neutral)
13.17
(11.03)
-16.25% Details
3/19/2026 4D Molecular Therapeutics FDMT Maintain Neutral
(Neutral)
 
 
  Details
9/23/2024 4D Molecular Therapeutics FDMT Downgrade Neutral
(Buy)
11.90
(11.03)
-7.31% Details